preCARDIA Leadership Team

Lisa Wipperman Heine
President & CEO

28+ years of experience in Medtech industry with significant focus on heart failure and cardiovascular devices.

Strong clinical development, regulatory strategy, reimbursement and market access expertise

Lisa Wipperman Heine
President & CEO
Tim Lenihan
CTO, Co-Founder, & Board Chair

26+ years of engineering and regulatory experience in US and EU.

Managed several CE Marking dossiers and FDA clearance/approvals

Tim Lenihan
CTO, Co-Founder, & Board Chair
Sara Vidmar
SVP, Clinical, Regulatory & Strategic Affairs

25+ years in the medical device space with significant focus on clinical trials in cardiovascular products and procedures.

Significant IDE/PMA, CE Mark and global clinical/regulatory strategy expertise

Sara Vidmar
SVP, Clinical, Regulatory & Strategic Affairs
Nancy Ness
Chief Financial Officer

30+ years of finance experience including CFO roles for multiple medical device companies, including preCARDIA.

Has provided financial and fundraising expertise to over 40 medical device and pharmaceutical early development and commercialization companies both in the US and abroad

Nancy Ness
Chief Financial Officer

preCARDIA Scientific Advisory Board

Navin Kapur, MD

Dual-boarded Interventional cardiologist and advanced heart failure specialist .

Global KOL for the field of acute and durable mechanical circulatory support.

Navin Kapur, MD
Richard Karas, MD PhD

Global KOL on vascular biology and endocrine function in CV disease .

Prior experience as CSO of Tufts MC and Exec Dir of the Molecular Cardiology Research Institute

Richard Karas, MD PhD
Dan Burkhoff, MD PhD

World-renowned expert in heart failure and hemodynamics.

Director of HF at the Cardiovascular Research Foundation.

Dan Burkhoff, MD PhD